Patents by Inventor Uladzimir A. Murauski

Uladzimir A. Murauski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9528992
    Abstract: Various embodiments of methods and kits are disclosed for detection and/or diagnosis of cancer (e.g., active malignancy) in a subject patient by analyzing a first sample of the subject patient's albumin-containing extracellular fluid (e.g., blood serum). Some embodiments comprise analyzing a second sample of the subject patient's albumin-containing extracellular fluid obtained between 2 and 90 days (e.g., between 5 and 30 days) after the first sample.
    Type: Grant
    Filed: February 20, 2013
    Date of Patent: December 27, 2016
    Inventor: Uladzimir A. Murauski
  • Publication number: 20150037907
    Abstract: Various embodiments of methods and kits are disclosed for detection and/or diagnosis of cancer (e.g., active malignancy) in a subject patient by analyzing a first sample of the subject patient's albumin-containing extracellular fluid (e.g., blood serum). Some embodiments comprise analyzing a second sample of the subject patient's albumin-containing extracellular fluid obtained between 2 and 90 days (e.g., between 5 and 30 days) after the first sample.
    Type: Application
    Filed: February 20, 2013
    Publication date: February 5, 2015
    Inventor: Uladzimir A. MURAUSKI
  • Patent number: 8632986
    Abstract: Various embodiments of methods and kits are disclosed for prognosis, detection, and/or diagnosis of toxemia in a subject patient by analyzing an aliquot of the subject patient's extracellular fluid (e.g., blood serum) that contains carrier proteins.
    Type: Grant
    Filed: November 21, 2008
    Date of Patent: January 21, 2014
    Inventor: Uladzimir A. Murauski
  • Publication number: 20110269245
    Abstract: Various embodiments of methods and kits are disclosed for prognosis, detection, and/or diagnosis of toxemia in a subject patient by analyzing an aliquot of the subject patient's extracellular fluid (e.g., blood serum) that contains carrier proteins.
    Type: Application
    Filed: November 21, 2008
    Publication date: November 3, 2011
    Inventor: Uladzimir A. Murauski